Amwise Diagnostic Company
Amwise Diagnostic is a leader in precision medicine technology for cancer. Our patented genetic analysis technologies assist doctors and patients in determining the most appropriate individualized treatment strategy that has optimal treatment effectiveness and minimal treatment-related adverse events.
%20.jpg)
%20.jpg)
Founded Date:
2015-01-01
Total Funding:
$10M
Employee Number:
11-50
Funding Status:
Early Stage Venture
Technology:
diagnostics
Last Funding Type:
Series B
Investors Number:
4
Last Funding Date:
2020-02-26
Industry:
Biotechnology, Health Care, Life Science
Headquarters:
Taipei, T'ai-pei, Taiwan
Estimated Revenue:
$1M to $10M